This bill proposes to amend the Arizona Revised Statutes by adding a new chapter that addresses the issue of price gouging for essential off-patent or generic drugs. It defines key terms such as "essential off-patent or generic drug," "price gouging," and "unconscionable increase," and establishes that manufacturers or wholesale distributors are prohibited from engaging in price gouging for these drugs. The bill outlines the conditions under which price increases may be reported to the attorney general and requires manufacturers to provide detailed cost information upon request.

Additionally, the bill grants the attorney general the authority to seek court orders to compel compliance, impose civil penalties, and restore funds to consumers affected by price gouging. It also ensures that any information provided by manufacturers during investigations remains confidential unless waived. Overall, the bill aims to protect consumers from excessive pricing of essential medications while providing a framework for accountability and transparency in the pharmaceutical market.